Heart health company Omron Healthcare Inc reported on Thursday the receipt of US FDA clearance for Complete, the first blood pressure monitor with EKG capability in a single device.
The company will open Complete pre-orders on 15 April in the US on OmronHealthcare.com for USD199.99, with retail availability expanding to Amazon beginning 1 May 2019.
According to the company, Complete is an upper arm blood pressure monitor that allows users to simultaneously monitor EKG and blood pressure readings at home. EKG readings can be measured by touching electrodes located on the top face and both sides of the monitor for easy access and comfort.
EKG is an essential measurement for those with atrial fibrillation, also known as arrythmia or Afib, which can lead to increased risk of stroke and heart failure. Complete uses an advanced new algorithm for improved detection of the possibility of Afib along with medical-grade blood pressure measurement.
QT Imaging signs exclusive USD33m distribution deal with Gulf Medical in Saudi Arabia
Novocure submits FDA PMA for Tumor Treating Fields therapy in pancreatic cancer
Covalon Technologies secures DTC eligibility to expand US investor access
Navamedic ASA secures final approvals for Flexilev in OraFID across Nordic markets
Oncopeptides partners with SD Pharma to expand Pepaxti access in Spain
Aptar launches bio-based nasal spray pump with Haleon's Otrivin brand
MAP Medical agrees distribution deal with Metrix-Secure
PharmaJet signs MOU with Egyptian UPA and EVA Pharma to introduce needle-free vaccine delivery
Alcon to acquire LumiThera and its FDA-authorised photobiomodulation device for dry AMD treatment
Predictmedix AI launches mobile diabetes screening platform in India
Navamedic's medical device OraFID approved as primary package for a pharmaceutical product
Speranza Therapeutics partners with Sunshine Labs for harm reduction solutions
Immuno Cure and PharmaJet collaborate for novel HIV therapeutic DNA vaccine advancement